{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:47:21Z","timestamp":1767988041629,"version":"3.49.0"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:00:00Z","timestamp":1639094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"National Institute of Health"},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Disease","doi-asserted-by":"crossref","award":["1-U01-AI124316"],"award-info":[{"award-number":["1-U01-AI124316"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["5T32HD087978-05"],"award-info":[{"award-number":["5T32HD087978-05"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To investigate the utility of recently approved delafloxacin and other fluoroquinolones against leading MDR bacterial pathogens under physiologically relevant conditions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>MIC and MBC assays were conducted for MDR strains of Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in the standard antibiotic susceptibility testing medium CAMHB, amended Roswell-Park Memorial Institute tissue culture medium (RPMI+) or 20% fresh human whole blood. In vivo correlation of in vitro findings was performed in a murine P. aeruginosa pneumonia model. Mechanistic bases for the findings were explored by altering media conditions and with established fluoroquinolone accumulation assays.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Fluoroquinolone MICs were increased in RPMI+ compared with CAMHB for all four MDR pathogens. Specifically, delafloxacin MICs were increased 32-fold versus MDR S. aureus and 8-fold versus MDR P. aeruginosa. MBC assays in 20% human whole blood and a murine MDR P. aeruginosa pneumonia model both confirmed that delafloxacin activity was reduced under physiological conditions. Bicarbonate (HCO3\u2212), a key component of host physiology found in RPMI+ but absent from CAMHB, dictated delafloxacin susceptibility in CAMHB and RPMI+ by impairing its intracellular accumulation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Standard in vitro antibiotic susceptibility testing conditions overpredicted the effectiveness of delafloxacin against MDR pathogens by failing to capture the role of the biological buffer HCO3\u2212 to impair delafloxacin accumulation. This work showcases limitations of our current antibiotic susceptibility testing paradigm and highlights the importance of understanding host microenvironmental conditions that impact true clinical efficacy.<\/jats:p><\/jats:sec>","DOI":"10.1093\/jac\/dkab421","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T20:12:45Z","timestamp":1635797565000},"page":"433-442","source":"Crossref","is-referenced-by-count":14,"title":["Bicarbonate modulates delafloxacin activity against MDR<i>Staphylococcus aureus<\/i>and<i>Pseudomonas aeruginosa<\/i>"],"prefix":"10.1093","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4917-9211","authenticated-orcid":false,"given":"Mische","family":"Holland","sequence":"first","affiliation":[{"name":"Department of Pediatrics, UC San Diego, La Jolla, CA 92093, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabet","family":"Bjanes","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, UC San Diego, La Jolla, CA 92093, USA"},{"name":"Collaborative to Halt Antibiotic-Resistant Microbes (CHARM), UC San Diego, La Jolla, CA 92093, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Nizet","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, UC San Diego, La Jolla, CA 92093, USA"},{"name":"Collaborative to Halt Antibiotic-Resistant Microbes (CHARM), UC San Diego, La Jolla, CA 92093, USA"},{"name":"Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego, La Jolla, CA 92093, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2351-0700","authenticated-orcid":false,"given":"Nicholas","family":"Dillon","sequence":"additional","affiliation":[{"name":"Collaborative to Halt Antibiotic-Resistant Microbes (CHARM), UC San Diego, La Jolla, CA 92093, USA"},{"name":"Department of Biological Sciences, UT Dallas, Richardson, TX 75080, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,12,10]]},"reference":[{"key":"2022021008143162700_dkab421-B1","author":"CDC","year":"2019"},{"key":"2022021008143162700_dkab421-B2","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE","volume":"197","author":"Rice","year":"2008","journal-title":"J Infect Dis"},{"key":"2022021008143162700_dkab421-B3","doi-asserted-by":"crossref","first-page":"e00181-19","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial resistance in ESKAPE pathogens","volume":"33","author":"De Oliveira","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"2022021008143162700_dkab421-B4","doi-asserted-by":"crossref","first-page":"e0189621","DOI":"10.1371\/journal.pone.0189621","article-title":"Clinical and economic impact of antibiotic resistance in developing countries: a systematic review and meta-analysis","volume":"12","author":"Founou","year":"2017","journal-title":"PLoS One"},{"key":"2022021008143162700_dkab421-B5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ebiom.2017.05.026","article-title":"Correcting a fundamental flaw in the paradigm for antimicrobial susceptibility testing","volume":"20","author":"Ersoy","year":"2017","journal-title":"EBioMedicine"},{"key":"2022021008143162700_dkab421-B6","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ebiom.2015.05.021","article-title":"Azithromycin synergizes with cationic antimicrobial peptides to exert bactericidal and therapeutic activity against highly multidrug-resistant Gram-negative bacterial pathogens","volume":"2","author":"Lin","year":"2015","journal-title":"EBioMedicine"},{"key":"2022021008143162700_dkab421-B7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ebiom.2019.07.041","article-title":"Surprising synergy of dual translation inhibition vs. Acinetobacter baumannii and other multidrug-resistant bacterial pathogens","volume":"46","author":"Dillon","year":"2019","journal-title":"EBioMedicine"},{"key":"2022021008143162700_dkab421-B8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/antibiotics8020060","article-title":"A pilot study of the synergy between two antimicrobial peptides and two common antibiotics","volume":"8","author":"Kampshoff","year":"2019","journal-title":"Antibiotics (Basel)"},{"key":"2022021008143162700_dkab421-B9","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.3389\/fmicb.2019.02740","article-title":"Synergy pattern of short cationic antimicrobial peptides against multidrug-resistant Pseudomonas aeruginosa","volume":"10","author":"Ruden","year":"2019","journal-title":"Front Microbiol"},{"key":"2022021008143162700_dkab421-B10","doi-asserted-by":"crossref","first-page":"e01520-16","DOI":"10.1128\/mBio.01520-16","article-title":"Collateral damage: detrimental effect of antibiotics on the development of protective immune memory","volume":"7","author":"Benoun","year":"2016","journal-title":"mBio"},{"key":"2022021008143162700_dkab421-B11","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.cell.2019.08.010","article-title":"Antibiotics-driven gut microbiome perturbation alters immunity to vaccines in humans","volume":"178","author":"Hagan","year":"2019","journal-title":"Cell"},{"key":"2022021008143162700_dkab421-B12","doi-asserted-by":"crossref","first-page":"8331","DOI":"10.1073\/pnas.1400352111","article-title":"Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections","volume":"111","author":"Ankomah","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022021008143162700_dkab421-B13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.chom.2017.10.020","article-title":"Antibiotic-induced changes to the host metabolic environment inhibit drug efficacy and alter immune function","volume":"22","author":"Yang","year":"2017","journal-title":"Cell Host Microbe"},{"key":"2022021008143162700_dkab421-B14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s15010-005-8207-x","article-title":"Contribution of immunocompetence to the antibacterial activities of ciprofloxacin and moxifloxacin in an in vitro pharmacodynamic model","volume":"33 Suppl 2","author":"Dalhoff","year":"2005","journal-title":"Infection"},{"key":"2022021008143162700_dkab421-B15","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1021\/acsinfecdis.7b00194","article-title":"Bicarbonate alters bacterial susceptibility to antibiotics by targeting the proton motive force","volume":"4","author":"Farha","year":"2018","journal-title":"ACS Infect Dis"},{"key":"2022021008143162700_dkab421-B16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/jac\/dkx433","article-title":"Bicarbonate induces high-level resistance to the human antimicrobial peptide LL-37 in Staphylococcus aureus small colony variants","volume":"73","author":"Zhang","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2022021008143162700_dkab421-B17","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.3389\/fmicb.2018.02245","article-title":"Bicarbonate inhibits bacterial growth and biofilm formation of prevalent cystic fibrosis pathogens","volume":"9","author":"Dobay","year":"2018","journal-title":"Front Microbiol"},{"key":"2022021008143162700_dkab421-B18","doi-asserted-by":"crossref","first-page":"e01852-17","DOI":"10.1128\/AAC.00496-19","article-title":"Bicarbonate resensitization of methicillin-resistant Staphylococcus aureus to \u03b2-lactam antibiotics","volume":"63","author":"Ersoy","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2022021008143162700_dkab421-B19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1096\/fj.05-4406com","article-title":"The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides","volume":"20","author":"Dorschner","year":"2006","journal-title":"FASEB J"},{"key":"2022021008143162700_dkab421-B20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1128\/AAC.17.2.103","article-title":"In vitro antibacterial activity of AM-715, a new nalidixic acid analog","volume":"17","author":"Ito","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"key":"2022021008143162700_dkab421-B21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1128\/AAC.23.4.559","article-title":"In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents","volume":"23","author":"Wise","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"key":"2022021008143162700_dkab421-B22","first-page":"433","article-title":"A review of levofloxacin for the treatment of bacterial infections","volume":"1","author":"Noel","year":"2009","journal-title":"Clin Med Ther"},{"key":"2022021008143162700_dkab421-B23","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/jcph.968","article-title":"A review of moxifloxacin for the treatment of drug-susceptible tuberculosis","volume":"57","author":"Naidoo","year":"2017","journal-title":"J Clin Pharmacol"},{"key":"2022021008143162700_dkab421-B24","author":"CDC","year":"2017"},{"key":"2022021008143162700_dkab421-B25","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"2022021008143162700_dkab421-B26","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/jac\/dkx543","article-title":"Clinical review of delafloxacin: a novel anionic fluoroquinolone","volume":"73","author":"Mogle","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2022021008143162700_dkab421-B27","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1093\/jac\/dks307","article-title":"Activity of delafloxacin against methicillin-resistant Staphylococcus aureus: resistance selection and characterization","volume":"67","author":"Remy","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2022021008143162700_dkab421-B28","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1128\/AAC.47.10.3260-3269.2003","article-title":"In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinolone","volume":"47","author":"Nilius","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"2022021008143162700_dkab421-B29","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1093\/cid\/ciy1079","article-title":"Profile of a novel anionic fluoroquinolone-delafloxacin","volume":"68","author":"Tulkens","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2022021008143162700_dkab421-B30","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1128\/AAC.04813-14","article-title":"A thorough QT study to evaluate the effects of therapeutic and supratherapeutic doses of delafloxacin on cardiac repolarization","volume":"59","author":"Litwin","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2022021008143162700_dkab421-B31","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1462-5822.2006.00858.x","article-title":"Global analysis of community-associated methicillin-resistant Staphylococcus aureus exoproteins reveals molecules produced in vitro and during infection","volume":"9","author":"Burlak","year":"2007","journal-title":"Cell Microbiol"},{"key":"2022021008143162700_dkab421-B32","doi-asserted-by":"crossref","first-page":"e01076-14","DOI":"10.1128\/mBio.01076-14","article-title":"AB5075, a highly virulent isolate of Acinetobacter baumannii, as a model strain for the evaluation of pathogenesis and antimicrobial treatments","volume":"5","author":"Jacobs","year":"2014","journal-title":"mBio"},{"key":"2022021008143162700_dkab421-B33","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/cmdc.201200150","article-title":"Selectively guanidinylated aminoglycosides as antibiotics","volume":"7","author":"Fair","year":"2012","journal-title":"ChemMedChem"},{"key":"2022021008143162700_dkab421-B34","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/AAC.46.3.813-820.2002","article-title":"Accumulation of 10 fluoroquinolones by wild-type or efflux mutant Streptococcus pneumoniae","volume":"46","author":"Piddock","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2022021008143162700_dkab421-B35","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/jac\/28.5.639","article-title":"A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus","volume":"28","author":"Mortimer","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"2022021008143162700_dkab421-B36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s42003-020-0929-x","article-title":"The challenge of intracellular antibiotic accumulation, a function of fluoroquinolone influx versus bacterial efflux","volume":"3","author":"Vergalli","year":"2020","journal-title":"Commun Biol"},{"key":"2022021008143162700_dkab421-B37","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.2215\/CJN.07400715","article-title":"Acid-base homeostasis","volume":"10","author":"Hamm","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022021008143162700_dkab421-B38","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1172\/JCI110821","article-title":"Effects of extracellular fluid volume and plasma bicarbonate concentration on proximal acidification in the rat","volume":"71","author":"Alpern","year":"1983","journal-title":"J Clin Invest"},{"key":"2022021008143162700_dkab421-B39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12941-016-0150-4","article-title":"Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin","volume":"15","author":"Kocsis","year":"2016","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2022021008143162700_dkab421-B40","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/infdis\/jiz128","article-title":"Avibactam sensitizes carbapenem-resistant NDM-1-producing Klebsiella pneumoniae to innate immune clearance","volume":"220","author":"Ulloa","year":"2019","journal-title":"J Infect Dis"},{"key":"2022021008143162700_dkab421-B41","doi-asserted-by":"crossref","first-page":"L126","DOI":"10.1152\/ajplung.00524.2016","article-title":"Acidosis increases the susceptibility of respiratory epithelial cells to Pseudomonas aeruginosa-induced cytotoxicity","volume":"313","author":"Torres","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2022021008143162700_dkab421-B42","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bbadis.2015.10.017","article-title":"Acidosis differently modulates the inflammatory program in monocytes and macrophages","volume":"1862","author":"Riemann","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"2022021008143162700_dkab421-B43","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.4049\/jimmunol.162.8.4849","article-title":"Extracellular acidification induces human neutrophil activation","volume":"162","author":"Trevani","year":"1999","journal-title":"J Immunol"},{"key":"2022021008143162700_dkab421-B44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fimmu.2015.00215","article-title":"Complement-coagulation cross-talk: a potential mediator of the physiological activation of complement by low pH","volume":"6","author":"Kenawy","year":"2015","journal-title":"Front Immunol"},{"key":"2022021008143162700_dkab421-B45","doi-asserted-by":"crossref","first-page":"74203","DOI":"10.18632\/oncotarget.12412","article-title":"Low pH impairs complement-dependent cytotoxicity against IgG-coated target cells","volume":"7","author":"Dantas","year":"2016","journal-title":"Oncotarget"},{"key":"2022021008143162700_dkab421-B46","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40121-018-0198-x","article-title":"Delafloxacin: place in therapy and review of microbiologic, clinical and pharmacologic properties","volume":"7","author":"Jorgensen","year":"2018","journal-title":"Infect Dis Ther"},{"key":"2022021008143162700_dkab421-B47","first-page":"605830","article-title":"The use of sodium bicarbonate in the treatment of acidosis in sepsis: a literature update on a long term debate","volume":"2015","author":"Velissaris","year":"2015","journal-title":"Crit Care Res Pract"},{"key":"2022021008143162700_dkab421-B48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4037\/ccn2015502","article-title":"Use of bicarbonate in patients with metabolic acidosis","volume":"35","author":"Ellis","year":"2015","journal-title":"Crit Care Nurse"},{"key":"2022021008143162700_dkab421-B49","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ajic.2014.09.022","article-title":"Breakthrough bacteremia in the neonatal intensive care unit: incidence, risk factors, and attributable mortality","volume":"43","author":"Tsai","year":"2015","journal-title":"Am J Infect Control"},{"key":"2022021008143162700_dkab421-B50","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1007\/s00268-008-9571-3","article-title":"Acinetobacter baumannii infections in a surgical intensive care unit: predictors of multi-drug resistance","volume":"32","author":"Katsaragakis","year":"2008","journal-title":"World J Surg"},{"key":"2022021008143162700_dkab421-B51","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jinf.2014.11.003","article-title":"Characteristics, risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit","volume":"70","author":"Vardakas","year":"2015","journal-title":"J Infect"},{"key":"2022021008143162700_dkab421-B52","doi-asserted-by":"crossref","first-page":"e00410-17","DOI":"10.1128\/mSphere.00410-17","article-title":"Interaction of antibiotics with innate host defense factors against Salmonella enterica serotype Newport","volume":"2","author":"Sakoulas","year":"2017","journal-title":"mSphere"},{"key":"2022021008143162700_dkab421-B53","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/ph9040067","article-title":"pH dependent antimicrobial peptides and proteins, their mechanisms of action and potential as therapeutic agents","volume":"9","author":"Malik","year":"2016","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/77\/2\/433\/42466954\/dkab421.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/77\/2\/433\/42466954\/dkab421.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T08:01:08Z","timestamp":1673683268000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/77\/2\/433\/6459101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,10]]},"references-count":53,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,12,10]]},"published-print":{"date-parts":[[2022,2,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkab421","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,2,1]]},"published":{"date-parts":[[2021,12,10]]}}}